fbpx
End the duopoly

A health care settlement parade

There’s still no settlement in the national opioids case, but plenty of other large health care cases have been laid to rest recently.

The bottom line: Allegations of wrongdoing are rampant in health care. For defendants, it’s often easier — and in their interest — to settle and eat the result as a cost of doing business.

Related Posts
1 of 1,088

Driving the news: None of these companies admitted wrongdoing.

  • Allergan is shelling out $750 million to settle allegations that it used tactics to impede generic competitors to one of its Alzheimer’s drugs.
  • 15 drug companies are paying a combined $248 million to resolve allegations they gamed the pricing system to inflate their payments from state Medicaid programs.
  • Sanford Health paid a $20 million settlement to kill a case that accused one of its neurosurgeons of performing unnecessary spine surgeries and profiting from the devices that were used.
  • Two disease-focused nonprofits paid a combined $6 million to clear allegations that pharmaceutical companies were using them as conduits to pay for patients’ medications.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More